摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,6,7,8-四氢-4H-环戊二烯并[E]咪唑并[1,2-a]吡嗪-4-酮 | 172901-76-7

中文名称
5,6,7,8-四氢-4H-环戊二烯并[E]咪唑并[1,2-a]吡嗪-4-酮
中文别名
法呢基4-O-吡喃阿拉伯糖基-吡喃阿拉伯糖苷-2,2',3-三乙酸酯
英文名称
5,6,7,8-Tetrahydro-4H-cyclopenta[E]imidazo[1,2-A]pyrazin-4-one
英文别名
1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),9,11-trien-8-one
5,6,7,8-四氢-4H-环戊二烯并[E]咪唑并[1,2-a]吡嗪-4-酮化学式
CAS
172901-76-7
化学式
C9H9N3O
mdl
——
分子量
175.19
InChiKey
KCWJNDFIQIVNJT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    46.9
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • DERIVES D'IMIDAZO[1,2-a]PYRAZINE-4-ONE, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT
    申请人:RHONE-POULENC RORER S.A.
    公开号:EP0752994A1
    公开(公告)日:1997-01-15
  • [EN] IMIDAZO[1,2-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME<br/>[FR] DERIVES D'IMIDAZO[1,2-a]PYRAZINE-4-ONE, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT
    申请人:RHONE-POULENC RORER S.A.
    公开号:WO1995026352A1
    公开(公告)日:1995-10-05
    (EN) Compounds of formula (I), wherein ring A is selected from rings 1, 2 and 3, wherein R is a CH2 radical or a sulphur, oxygen or nitrogen atom substituted by an alkyl radical, salts thereof, preparation thereof and drugs containing same. The compounds of formula (I) have valuable pharmacological properties and are alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists, said receptor also being known as the quisqualate receptor. Furthermore, the compounds of formula (I) are non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists, and particularly NMDA receptor glycine modulation site ligands.(FR) Composés de formule (I) dans laquelle le cycle A est choisi parmi les cycles (1, 2 et 3) dans lesquels R représente un radical CH2 ou un atome de soufre, d'oxygène ou d'azote substitué par un radical alkyle, leurs sels, leur préparation et les médicaments les contenant. Les composés de formule (I) présentent des propriétés pharmacologiques intéressantes. Ces composés sont des antagonistes du récepteur de l'acide $g(a)-amino-3-hydroxy-5-méthyl-4-isoxazolepropionique (AMPA), connu aussi sous le nom de récepteur du quisqualate. Par ailleurs, les composés de formule (I) sont des antagonistes non compétitifs du récepteur N-méthyl-D-aspartate (NMDA) et, plus particulièrement, ce sont des ligands pour les sites modulateurs de la glycine du récepteur NMDA.
查看更多

同类化合物

咪唑并[1,2-a]噻吩并[3,2-E]吡嗪-5(4H)-酮 8-羟基咪唑并[1,2-a]吡嗪 5H,10H-二咪唑并[1,2-a:1,2-d]吡嗪-5,10-二酮 5H,10H-二咪唑并[1,2-a:1',5'-d]吡嗪-5,10-二酮 5,6,7,8-四氢-4H-环戊二烯并[E]咪唑并[1,2-a]吡嗪-4-酮 3-bromo-7-phenethyl-7H-imidazo[1,2-a]pyrazin-8-one 8-(3-phenylpropionamido)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 5-chloro-6-methyl-8-oxo-7-phenyl-7,8-dihydroimidazo[1,2-a]-pyrazine-3-carbaldehyde 5-chloro-6,7-dimethyl-8-oxo-7,8-dihydroimidazo[1,2-a]pyrazine-3-carbaldehyde 10-methoxyimino-5H,10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-4-one 3-bromo-7-ethyl-7H-imidazo[1,2-a]pyrazin-8-one 7-(4-methoxyphenyl)-3-methyl-5-phenylimidazo[1,2-a]pyrazin-8(7H)-one tert-butyl N-[2-[[6-(2-trimethylsilylethynyl)imidazo[1,2-a]pyrazin-8-yl]amino]ethyl]carbamate 7-(4-methoxyphenyl)-3-methyl-5-p-tolylimidazo[1,2-a]pyrazin-8(7H)-one 5-chloro-7-(4-methoxyphenyl)-8-oxo-7,8-dihydroimidazo[1,2-a]-pyrazine-3-carbaldehyde 10-(2-carboxybenzyl)-5H,10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-4-one ethyl 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one-10-carboxylate 10-hydroxyimino-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid 10-(phenylpropyl)-5H,10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-4-one 8-chloro-5H, 10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one hydrochloride sodium salt of 10-carboxymethylene-7-chloro-5H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-4-one 9-methyl-5H, 10H-imidazo [1,2-a]indeno[1,2-e]pyrazin-4-one hydrochloride 8-(N,N-dimethylaminocarbonylmethyl)-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid 4-Cyclopropyl-7-fluoro-5-methyl-6-pyrazin-2-ylpyrido[1,2-c]pyrimidine-1,3-dione N-benzyl-(4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-9-yl)carboxamide 10-(3-carboxybenzylidene)-5H,10H-imidazo-[1,2-a]indeno[1,2-e]pyrazin-4-one N-methoxy-3-(2-methoxy-6,7-dimethylimidazo[1,5-a]pyrido[3,2-e]pyrazin-9-yl)benzamide 2-methyl-7-(4-nitrophenethyl)-7H-imidazo[1,2-a]pyrazin-8-one monohydrochloride 7-[1-(4-chloro-phenyl)-cyclopropylmethyl]-2-methyl-7H-imidazo[1,2-a]pyrazin-8-one monohydrochloride 7-(4-methoxybenzyl)-3-methyl-5-(thiophen-3-yl)imidazo[1,2-a]pyrazin-8(7H)-one ethyl 8-nitro-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]-pyrazine-2-carboxylate 5-chloro-7-(4-methoxybenzyl)-6-(4-methoxyphenyl)-3-methylimidazo[1,2-a]pyrazin-8(7H)-one 3-bromo-7-(1-phenyl-cyclopropylmethyl)-7H-imidazo[1,2-a]pyrazin-8-one [4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-8-yl]acetic acid hydrochloride Methyl-(10-methyl-4-oxo-5,10-dihydro-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-yl)-carbamic acid tert-butyl ester 10-hydroxyimino-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 5H,10H-diimidazo(1,2-a:1',2'-d)pyrazine-5,10-dione dihydrochloride 9-acetamido-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 6-(2-chlorophenyl)-7H-imidazo[1,2-a]pyrazin-8-one 10-(4-aminobenzyl)-5H,10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-4-one 10-amino-10-isopropyl-5H,10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-4-one 2-methyl-7-phenylimidazo[1,2-a]pyrazin-8(7H)-one 7-phenyl-2-(tetrahydro-2H-pyran-3-yl)imidazo[1,2-a]pyrazin-8(7H)-one 9-(2-isopropoxyphenyl)-2-methoxy-6,7-dimethylimidazo[1,5-a]pyrido[3,2-e]pyrazine 2-(tert-butyl)-7-phenylimidazo[1,2-a]pyrazin-8(7H)-one 10-propionamido-5H,10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-4-one 8-nitro-10-(carboxymethylene)-5H,10H-imidazo-[1,2-a]indeno[1,2-e]pyrazin-4-one 10-(4-piperidylmethyl)-5H,10H-imidazo[1,2-a]-indeno[1,2-e]pyrazin-4-one 10-(3-aminobenzylidene)-5H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-4-one